Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-17
DOI
10.3389/fimmu.2017.01961
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospects of a type 1 diabetes vaccine
- (2017) Dana P. Cook et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A review on Lactococcus lactis: from food to factory
- (2017) Adelene Ai-Lian Song et al. Microbial Cell Factories
- Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies
- (2017) Tian Tian et al. Oxidative Medicine and Cellular Longevity
- Hsp65-Producing Lactococcus lactis Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways
- (2017) Ana Cristina Gomes-Santos et al. Frontiers in Immunology
- A Novel Interleukin-10 Dna Mucosal Delivery System Attenuates Intestinal Inflammation in a Mouse Model
- (2017) S. Del Carmen et al. European Journal of Inflammation
- The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial
- (2017) Zlatan Mujagic et al. Scientific Reports
- Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs)
- (2016) Tomasz Koliński et al. Central European Journal of Immunology
- Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10–Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells
- (2016) Tatiana Takiishi et al. DIABETES
- Protease inhibition as new therapeutic strategy for GI diseases
- (2016) Nathalie Vergnolle GUT
- Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice
- (2016) Kun-Feng Liu et al. IMMUNOLOGY LETTERS
- Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications
- (2016) C. Michon et al. Microbial Cell Factories
- The Polymorphism rs3024505 (C/T) Downstream of the IL10 Gene Is Associated with Crohn’s Disease in Serbian Patients with Inflammatory Bowel Disease
- (2016) Dragana Mijac et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
- (2016) Abdul Muheem et al. SAUDI PHARMACEUTICAL JOURNAL
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis
- (2015) Jeevanathan Kalyanasundram et al. BMC BIOTECHNOLOGY
- The immunology of asthma
- (2015) Bart N Lambrecht et al. NATURE IMMUNOLOGY
- Host lysozyme-mediated lysis ofLactococcus lactisfacilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons
- (2015) Sonia A. Ballal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression inLactococcus lactis
- (2015) S. Robert et al. Beneficial Microbes
- Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis
- (2014) Meritxell Zurita-Turk et al. BMC BIOTECHNOLOGY
- Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice
- (2014) S. Robert et al. DIABETES
- Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice
- (2014) Yanjun Ma et al. PLoS One
- Genetically Engineered Lactococcus lactis Protect against House Dust Mite Allergy in a BALB/c Mouse Model
- (2014) Chunqing Ai et al. PLoS One
- Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients
- (2014) Kei Kawana et al. VACCINE
- Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis
- (2014) Tessalia Luerce et al. Gut Pathogens
- Changes of the human gut microbiome induced by a fermented milk product
- (2014) Patrick Veiga et al. Scientific Reports
- Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation
- (2014) Rebeca Martín et al. Human Vaccines & Immunotherapeutics
- Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
- (2014) Sabina Fijan International Journal of Environmental Research and Public Health
- Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy
- (2013) Sewanti Atul Limaye et al. CANCER
- Trials in type 1 diabetes: Antigen-specific therapies
- (2013) Ken T. Coppieters et al. CLINICAL IMMUNOLOGY
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles
- (2013) Alan Rigter et al. PLoS One
- Antigen-Specific Therapeutic Approaches in Type 1 Diabetes
- (2013) X. Clemente-Casares et al. Cold Spring Harbor Perspectives in Medicine
- Retinoic acid-producing DCs and gut-tropic FOXP3+regulatory T cells in the induction of oral tolerance
- (2013) Eduardo J. Villablanca OncoImmunology
- IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis
- (2012) Christopher J. Moran et al. INFLAMMATORY BOWEL DISEASES
- Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
- (2012) Tatiana Takiishi et al. JOURNAL OF CLINICAL INVESTIGATION
- Oral administration of milk fermented with Lactococcus lactis subsp. cremoris FC protects mice against influenza virus infection
- (2012) T. Maruo et al. LETTERS IN APPLIED MICROBIOLOGY
- Oral tolerance to food protein
- (2012) O Pabst et al. Mucosal Immunology
- Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
- (2011) Samuel Huber et al. IMMUNITY
- Oral tolerance
- (2011) Howard L. Weiner et al. IMMUNOLOGICAL REVIEWS
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
- (2011) Luis G Bermúdez-Humarán et al. Microbial Cell Factories
- Genetic Evidence Supporting the Association of Protease and Protease Inhibitor Genes with Inflammatory Bowel Disease: A Systematic Review
- (2011) Isabelle Cleynen et al. PLoS One
- Lactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems
- (2011) Daniela Santos Pontes et al. PROTEIN EXPRESSION AND PURIFICATION
- Intestinal CD103+ dendritic cells: master regulators of tolerance?
- (2011) Charlotte L. Scott et al. TRENDS IN IMMUNOLOGY
- Genetically ModifiedLactococcus lactisfor Delivery of Human Interleukin-10 to Dendritic Cells
- (2011) Inge L. Huibregtse et al. Gastroenterology Research and Practice
- The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study
- (2010) Vibeke Andersen et al. BMC Medical Genetics
- An intranasal administration of Lactococcus lactis strains expressing recombinant interleukin-10 modulates acute allergic airway inflammation in a murine model
- (2010) F. A. V. Marinho et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)
- (2010) T. T. MACDONALD CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitis
- (2010) T. R. J. STEVENS et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
- (2010) J. B. Matthews et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- 46 A Phase 2a Randomized Placebo-Controlled Double-Blind Multi-Center Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Patients With Moderately Active Ulcerative Colitis
- (2010) Severine Vermeire et al. GASTROENTEROLOGY
- Genome Sequences of Lactococcus lactis MG1363 (Revised) and NZ9000 and Comparative Physiological Studies
- (2010) D. M. Linares et al. JOURNAL OF BACTERIOLOGY
- Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice
- (2010) Jean Guy LeBlanc et al. JOURNAL OF BIOTECHNOLOGY
- Cutting Edge: IFN- Is a Negative Regulator of IL-23 in Murine Macrophages and Experimental Colitis
- (2010) S. Z. Sheikh et al. JOURNAL OF IMMUNOLOGY
- AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis
- (2010) Silvia Caluwaerts et al. ORAL ONCOLOGY
- Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes
- (2010) P. Veiga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Actobiotics™ as a Novel Method for Cytokine Delivery
- (2009) Lothar Steidler et al. Annals of the New York Academy of Sciences
- Probiotics: multifarious oral vaccine against infectious traumas
- (2009) Sarika Amdekar et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury
- (2009) D. Frenkel et al. INTERNATIONAL IMMUNOLOGY
- Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Recombinant Human Intestinal Trefoil Factor Oral Spray for Prevention of Oral Mucositis in Patients With Colorectal Cancer Who Are Receiving Fluorouracil-Based Chemotherapy
- (2009) Douglas E. Peterson et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of Antigen-Specific Tolerance by Oral Administration of Lactococcus lactis Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab Dq8 Transgenic Mice
- (2009) I. L. Huibregtse et al. JOURNAL OF IMMUNOLOGY
- Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
- (2009) K Vandenbroucke et al. Mucosal Immunology
- Heat Shock Protein-Derived T-Cell Epitopes Contribute to Autoimmune Inflammation in Pediatric Crohn's Disease
- (2009) Gisella L. Puga Yung et al. PLoS One
- Production of biological active murine IFN-γ by recombinant Lactococcus lactis
- (2008) Luis G. Bermúdez-Humarán et al. FEMS MICROBIOLOGY LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started